CytomX Therapeutics Income Statement (2014-2025) | CTMX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Sep2014	Dec2014	Mar2015	Jun2015	Sep2015	Dec2015	Mar2016	Jun2016	Sep2016	Dec2016	Mar2017	Jun2017	Sep2017	Dec2017	Mar2018	Jun2018	Sep2018	Dec2018	Mar2019	Jun2019	Sep2019	Dec2019	Mar2020	Jun2020	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025
Revenue & cost
Revenue	1.92M	1.86M	1.74M	2.04M	1.94M	1.99M	2.22M	3.09M	3.45M	6.27M	11.65M	8.75M	24.14M	27.07M	14.18M	9.90M	12.51M	11.47M	18.10M	9.01M	10.71M	8.28M	26.60M	6.99M	7.47M	7.08M	8.20M	8.79M	9.19M	11.13M	9.04M	12.85M	11.15M	20.12M	23.50M	24.72M	26.38M	26.61M	41.46M	25.11M	33.43M	38.09M	50.92M	18.66M	5.96M
Operating items
Research & Development	3.92M	4.34M	4.66M	5.03M	9.16M	9.50M	13.37M	12.71M	13.34M	15.35M	14.58M	28.08M	28.92M	20.70M	22.46M	25.55M	27.55M	28.31M	36.38M	30.84M	27.97M	36.44M	42.81M	24.07M	24.05M	22.01M	22.37M	26.10M	29.14M	36.58M	30.56M	31.16M	30.37M	19.56M	21.18M	20.67M	16.45M	19.39M	22.05M	25.17M	21.37M	14.79M	18.87M	13.32M	15.30M
Selling, General & Administrative	1.46M	2.18M	1.95M	2.55M	4.05M	4.01M	5.04M	4.65M	5.03M	5.15M	5.69M	6.05M	6.25M	7.62M	7.36M	9.04M	8.14M	8.97M	9.67M	9.41M	8.46M	9.22M	9.57M	8.68M	8.63M	9.14M	9.23M	9.39M	11.09M	9.46M	10.54M	11.75M	10.49M	10.07M	7.98M	7.40M	6.81M	7.83M	7.75M	8.39M	7.95M	5.62M	9.43M	6.62M	6.43M
Operating Expenses	5.38M	6.52M	6.61M	7.58M	13.21M	13.51M	18.41M	17.35M	18.37M	20.50M	20.27M	34.12M	35.17M	28.32M	29.81M	34.59M	35.69M	37.28M	46.05M	40.25M	36.43M	45.66M	52.39M	32.75M	32.68M	31.15M	31.60M	35.49M	40.23M	46.03M	41.10M	42.91M	40.86M	29.63M	29.15M	28.07M	23.26M	27.21M	29.81M	33.57M	29.32M	20.41M	28.30M	19.94M	21.73M
Operating Income	-3.46M	-4.66M	-4.87M	-5.54M	-11.27M	-11.52M	-16.18M	-14.26M	-14.92M	-14.23M	-8.61M	-25.37M	-11.03M	-1.25M	-15.63M	-13.26M	-23.18M	-25.81M	-16.57M	-31.23M	-25.72M	-67.97M	-5.49M	-25.76M	-25.22M	-24.07M	-23.40M	-26.70M	-31.04M	-34.90M	-32.06M	-30.05M	-29.71M	-9.51M	-5.65M	-3.35M	3.12M	-0.61M	11.66M	-8.45M	4.11M	17.68M	22.62M	-1.29M	-15.77M
EBIT	-3.46M	-4.66M	-4.87M	-5.54M	-11.27M	-11.52M	-16.18M	-14.26M	-14.92M	-14.23M	-8.61M	-25.37M	-11.03M	-1.25M	-15.63M	-13.26M	-23.18M	-25.81M	-16.57M	-31.23M	-25.72M	-67.97M	-5.49M	-25.76M	-25.22M	-24.07M	-23.40M	-26.70M	-31.04M	-34.90M	-32.06M	-30.05M	-29.71M	-9.51M	-5.65M	-3.35M	3.12M	-0.61M	11.66M	-8.45M	4.11M	17.68M	22.62M	-1.29M	-15.77M
Non-operating items
Interest & Investment Income	0.00M	0.00M	0.14M	0.33M	0.41M	0.44M	0.49M	0.20M	0.21M	0.19M	0.24M	0.36M	0.81M	1.27M	1.38M	1.54M	2.22M	2.51M	2.50M	2.36M	2.00M	1.51M	1.07M	0.45M	0.20M	0.11M	0.07M	0.04M	0.07M	0.07M	0.07M	0.26M	0.62M	0.73M	2.33M	2.31M	2.70M	2.50M	2.19M	1.97M	1.69M	1.28M	0.95M	1.18M	1.59M
Other Non Operating Income	-0.01M	-0.01M	-1.25M	-0.18M	-0.29M	-0.03M	0.02M	-0.11M	0.04M	-0.02M	0.12M	-0.17M	-0.05M	0.07M	-0.14M	0.06M	0.03M	-0.02M	-0.06M	-0.09M	0.02M	-0.01M	0.01M	0.01M	-0.01M	-0.03M	0.01M	-0.08M	-0.01M	0.01M	0.01M	0.30M	0.03M	0.00M	0.01M	-0.05M	-0.01M	0.01M	-0.01M	-0.00M	-0.01M	-0.02M	0.01M	0.02M	0.01M
Non Operating Income	-0.01M	-0.01M	-1.25M	-0.18M	-0.29M	-0.03M	0.02M	-0.11M	0.04M	-0.02M	0.12M	-0.17M	-0.05M	0.07M	-0.14M	0.06M	0.03M	-0.02M	-0.06M	-0.09M	0.02M	-0.01M	0.01M	0.01M	-0.01M	-0.03M	0.01M	-0.08M	-0.01M	0.01M	0.01M	0.30M	0.03M	0.00M	0.01M	-0.05M	-0.01M	0.01M	-0.01M	-0.00M	-0.01M	-0.02M	0.01M	0.02M	0.01M
Net income details
EBT	-3.59M	-4.78M	-6.21M	-5.80M	-11.87M	-11.48M	-16.03M	-14.17M	-14.66M	-14.06M	-8.26M	-25.19M	-10.27M	0.10M	-14.39M	-11.66M	-20.93M	-23.32M	-14.13M	-28.96M	-23.70M	-66.46M	-4.40M	-25.30M	-25.03M	-24.00M	-23.33M	-26.74M	-30.98M	-34.82M	-31.98M	-29.50M	-29.06M	-8.78M	-3.31M	-1.09M	5.82M	1.91M	13.84M	-6.48M	5.80M	18.94M	23.59M	-0.09M	-14.17M
Tax Provisions					0.00M	0.00M	0.00M	0.00M	0.00M	-0.03M	-0.00M	0.03M	-0.02M	-0.52M	1.10M	1.80M	2.50M	8.91M	-0.01M			-0.42M	-13.91M														2.82M	1.07M	0.05M	0.05M	0.06M	0.06M	0.06M	0.06M	0.06M
Profit After Tax	-3.59M	-4.79M	-6.21M	-5.81M	-11.87M	-11.49M	-16.03M	-14.18M	-14.66M	-14.03M	-8.26M	-25.22M	-10.25M	0.62M	-15.49M	-13.45M	-23.43M	-32.23M	-14.12M	-28.96M	-23.70M	-35.45M	9.51M	-25.30M	-25.03M	-24.00M	-23.33M	-26.74M	-30.98M	-34.82M	-31.98M	-29.50M	-29.06M	-8.78M	-3.31M	-1.09M	2.99M	0.84M	13.79M	-6.53M	5.74M	18.88M	23.52M	-0.15M	-14.23M
Income from Continuing Operations	-3.59M	-4.78M	-6.21M	-5.80M	-11.87M	-11.49M	-16.03M	-14.18M	-14.66M	-14.03M	-8.26M	-25.22M	-10.25M	0.62M	-15.49M	-13.46M	-23.43M	-32.23M	-14.12M	-28.96M	-23.70M	-66.04M	9.51M	-25.30M	-25.03M	-24.00M	-23.33M	-26.74M	-30.98M	-34.82M	-31.98M	-29.50M	-29.06M	-8.78M	-3.31M	-1.09M	2.99M	0.84M	13.79M	-6.53M	5.74M	18.88M	23.52M	-0.15M	-14.23M
Consolidated Net Income	-3.59M	-4.78M	-6.21M	-5.80M	-11.87M	-11.49M	-16.03M	-14.18M	-14.66M	-14.03M	-8.26M	-25.22M	-10.25M	0.62M	-15.49M	-13.46M	-23.43M	-32.23M	-14.12M	-28.96M	-23.70M	-66.04M	9.51M	-25.30M	-25.03M	-24.00M	-23.33M	-26.74M	-30.98M	-34.82M	-31.98M	-29.50M	-29.06M	-8.78M	-3.31M	-1.09M	2.99M	0.84M	13.79M	-6.53M	5.74M	18.88M	23.52M	-0.15M	-14.23M
Income towards Parent Company	-3.59M	-4.78M	-6.21M	-5.80M	-11.87M	-11.49M	-16.03M	-14.18M	-14.66M	-14.03M	-8.26M	-25.22M	-10.25M	0.62M	-15.49M	-13.46M	-23.43M	-32.23M	-14.12M	-28.96M	-23.70M	-66.04M	9.51M	-25.30M	-25.03M	-24.00M	-23.33M	-26.74M	-30.98M	-34.82M	-31.98M	-29.50M	-29.06M	-8.78M	-3.31M	-1.09M	2.99M	0.84M	13.79M	-6.53M	5.74M	18.88M	23.52M	-0.15M	-14.23M
Preferred Dividend Payments	1.17M	1.20M	1.43M	1.76M	2.96M	0.56M
Net Income towards Common Stockholders	-4.76M	-5.98M	-7.64M	-7.56M	-14.83M	-12.04M	-16.03M	-14.18M	-14.66M	-14.03M	-8.26M	-25.22M	-10.25M	0.62M	-15.49M	-13.46M	-23.43M	-32.23M	-14.12M	-28.96M	-23.70M	-66.04M	9.51M	-25.30M	-25.03M	-24.00M	-23.33M	-26.74M	-30.98M	-34.82M	-31.98M	-29.50M	-29.06M	-8.78M	-3.31M	-1.09M	2.99M	0.84M	13.79M	-6.53M	5.74M	18.88M	23.52M	-0.15M	-14.23M
Additional items
EPS (Basic)	-4.86	-6.03	-7.67	-7.56	-14.26	-0.39	-0.44	-0.39	-0.40	-0.39	-0.23	-0.69	-0.28	0.02	-0.40	-0.35	-0.53	-0.72	-0.31	-0.64	-0.52	-0.78	0.21	-0.55	-0.54	-0.51	-0.38	-0.41	-0.48	-0.53	-0.49	-0.45	-0.44	-0.13	-0.05	-0.02	0.04	0.01	0.17	-0.08	0.07	0.23	0.27	0.00	-0.09
EPS (Weighted Average and Diluted)																			-0.31			-1.46	0.20	-0.55	-0.54	-0.51	-0.38	-0.41	-0.48	-0.53	-0.49	-0.45	-0.44	-0.13	-0.05	-0.02	0.04	0.01	0.17	-0.08	0.07	0.23	0.27		-0.09
Shares Outstanding (Weighted Average)				0.57M	0.57M	36.02M	36.08M	36.09M	36.29M	36.40M	36.52M	36.75M	36.87M	38.41M	38.61M	38.96M	44.96M	45.01M	45.11M	45.31M	45.41M	45.43M	45.57M	45.92M	46.19M	46.22M	64.78M	65.01M	65.16M	65.25M	65.39M	65.40M	65.95M	66.08M	66.23M	66.34M	66.77M	66.99M	67.72M	77.92M	78.12M	78.26M	80.10M	80.62M	164.91M
Shares Outstanding (Diluted Average)																						45.34M	47.04M	46.06M	46.20M	46.60M	60.97M	65.06M	65.21M	65.30M	65.39M	65.54M	65.91M	65.74M	66.25M	66.54M		73.81M
EBITDA	-3.59M	-4.79M	-6.22M	-5.80M	-11.88M	-11.55M	-15.92M	-14.13M	-14.73M	-14.07M	-8.33M	-25.23M	-10.20M	0.59M	-15.63M	-13.40M	-23.46M	-32.12M	-13.96M	-28.82M	-23.80M	-66.10M	9.79M	-25.62M	-25.09M	-24.00M	-23.32M	-26.68M	-30.95M	-35.12M	-32.66M	-29.74M	-28.70M	-7.97M	-3.29M	-1.08M	2.89M	0.99M	13.69M	-6.53M	5.78M	18.86M	23.50M	-0.12M	-14.16M
Interest Expenses	0.12M	0.11M	0.23M	0.41M	0.72M	0.38M	0.35M	0.47M	0.48M	0.39M	0.21M
Tax Rate										0.18%	0.01%		0.19%						0.04%			0.63%															48.55%	56.09%	0.35%		1.05%	0.33%	0.26%

Research Tools

CytomX Therapeutics Income Statement (2014-2025) | CTMX

Create an account

Sign In

Reset Password

Get Pro for 60% off